Solid Biosciences Inc. SLDB Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s total liabilities?
- Solid Biosciences Inc. (SLDB) reported total liabilities of $48.76M in Q1 2026.
- How has Solid Biosciences Inc.'s total liabilities changed year-over-year?
- Solid Biosciences Inc.'s total liabilities decreased by 1.4% year-over-year, from $49.44M to $48.76M.
- What is the long-term trend for Solid Biosciences Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s total liabilities has grown at a 6.1% compound annual growth rate (CAGR), from $39.08M to $52.53M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.